The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Combined oral contraceptives: venous thrombosis
Open accessAbstract
BACKGROUND: Combined oral contraceptive (COC) use has been associated with venous thrombosis (VT) (i.e., deep venous thrombosis and pulmonary embolism). The VT risk has been evaluated for many estrogen doses and progestagen types contained in COC but no comprehensive comparison involving commonly used COC is available. OBJECTIVES: To provide a comprehensive overview of the risk of venous thrombosis in women using different combined oral contraceptives. SEARCH METHODS: Electronic databases (Pubmed, Embase, Web of Science, Cochrane, CINAHL, Academic Search Premier and ScienceDirect) were searched in 22 April 2013 for eligible studies, without language restrictions. SELECTION CRITERIA: We selected studies including healthy women taking COC with VT as outcome. DATA COLLECTION AND ANALYSIS: The primary outcome of interest was a fatal or non-fatal first event of venous thrombosis with the main focus on deep venous thrombosis or pulmonary embolism. Publications with at least 10 events in total were eligible. The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported.Two independent reviewers extracted data from selected studies. MAIN RESULTS: 3110 publications were retrieved through a search strategy; 25 publications reporting on 26 studies were included. Incidence of venous thrombosis in non-users from two included cohorts was 0.19 and 0.37 per 1 000 person years, in line with previously reported incidences of 0,16 per 1 000 person years. Use of combined oral contraceptives increased the risk of venous thrombosis compared with non-use (relative risk 3.5, 95% confidence interval 2.9 to 4.3). The relative risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate, or drospirenone were similar and about 50-80% higher than for combined oral contraceptives with levonorgestrel. A dose related effect of ethinylestradiol was observed for gestodene, desogestrel, and levonorgestrel, with higher doses being associated with higher thrombosis risk. AUTHORS' CONCLUSIONS: All combined oral contraceptives investigated in this analysis were associated with an increased risk of venous thrombosis. The effect size depended both on the progestogen used and the dose of ethinylestradiol. Risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate and drospirenone were similar, and about 50-80% higher than with levonorgestrel. The combined oral contraceptive with the lowest possible dose of ethinylestradiol and good compliance should be prescribed-that is, 30 μg ethinylestradiol with levonorgestrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
The Epidemiology of Venous Thromboembolism
White, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000078468.11849.66 · Cited by 2,310
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Self-citationWhite, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citationNatural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Universities and tobacco money: Some universities are accomplices in the tobacco epidemic
Cohen, J. E. (2001) · BMJ · doi:10.1136/bmj.323.7303.1 · Cited by 943
Accuracy of clinical assessment of deep-vein thrombosis
Wells, P., Hirsh, J., Anderson, D., Lensing, A. A., Foster, G., Kearon, C., Weitz, J., D'Ovidio, R., Cogo, A., Prandoni, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92535-x · Cited by 798
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C. (2009) · BMJ · doi:10.1136/bmj.b2890 · Cited by 709
van Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 666
Self-citationWorld Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631
Inman, W. H. W., Vessey, M. P., Westerholm, B., & Engelund, A. (1970) · BMJ · doi:10.1136/bmj.2.5703.203 · Cited by 611
Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., & Lokkegaard, E. (2011) · BMJ · doi:10.1136/bmj.d6423 · Cited by 608
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Self-citationOral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Self-citationProspective study of exogenous hormones and risk of pulmonary embolism in women
Grodstein, F., Stampfer, M. J., Goldhaber, S. Z., Manson, J. E., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hennekens, C. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07308-4 · Cited by 571
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 470
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
Inman, W. H., & Vessey, M. P. (1968) · BMJ · doi:10.1136/bmj.2.5599.193 · Cited by 452
Stegeman, B. H., de Bastos, M., Rosendaal, F. R., van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2013) · BMJ · doi:10.1136/bmj.f5298 · Cited by 420
Self-citationObservational research, randomised trials, and two views of medical science
Vandenbroucke, J. P. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050067 · Cited by 416
Huerta, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.935 · Cited by 408
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Vessey, M. P., & Doll, R. (1969) · BMJ · doi:10.1136/bmj.2.5658.651 · Cited by 403
ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT
Böttiger, L. E., Boman, G., Eklund, G., & Westerholm, B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91550-0 · Cited by 394
Jansen, J. P., Crawford, B., Bergman, G., & Stam, W. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00347.x · Cited by 385
Pharmacological profile of progestins
Sitruk-Ware, R. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.01.001 · Cited by 374
New progestagens for contraceptive use
Sitruk-Ware, R. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi046 · Cited by 362
Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease
Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W. J., Stadel, B. V., & Lundin, F. E. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115799 · Cited by 352
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Meade, T. W., Greenberg, G., & Thompson, S. G. (1980) · BMJ · doi:10.1136/bmj.280.6224.1157 · Cited by 309
The Leiden Thrombophilia Study (LETS)
Meer, F. J. M. V. D., Koster, T., Vandenbroucke, J. P., Briët, E., & Rosendaal, F. R. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657602 · Cited by 275
Self-citationGolder, S., Loke, Y. K., & Bland, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001026 · Cited by 269
Oral contraceptives and venous thromboembolism: findings in a large prospective study.
Vessey, M., Mant, D., Smith, A., & Yeates, D. (1986) · BMJ · doi:10.1136/bmj.292.6519.526 · Cited by 259
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Jick, S. S., & Hernandez, R. K. (2011) · BMJ · doi:10.1136/bmj.d2151 · Cited by 238
Jordan, W. M., & Anand, J. K. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91061-3 · Cited by 223
(1973) · The Lancet · doi:10.1016/s0140-6736(73)91735-2 · Cited by 213
Risk factors for thrombophilia in extrahepatic portal vein obstruction†
Primignani, M., Martinelli, I., Bucciarelli, P., Battaglioli, T., Reati, R., Fabris, F., Dell'Era, A., Pappalardo, E., & Mannucci, P. M. (2005) · Hepatology · doi:10.1002/hep.20591 · Cited by 207
Parkin, L., Sharples, K., Hernandez, R. K., & Jick, S. S. (2011) · BMJ · doi:10.1136/bmj.d2139 · Cited by 203
First-time use of newer oral contraceptives and the risk of venous thromboembolism
Suissa, S., Blais, L., Spitzer, W. O., Cusson, J., Lewis, M., & Heinemann, L. (1997) · Contraception · doi:10.1016/s0010-7824(97)00119-4 · Cited by 191
THROMBOSIS WITH LOW-ESTROGEN ORAL CONTRACEPTIVES
STOLLEY, P. D., TONASCIA, J. A., TOCKMAN, M. S., SARTWELL, P. E., RUTLEDGE, A. H., & JACOBS, M. P. (1975) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112148 · Cited by 187
Oral contraceptives and venous thromboembolism
Lidegaard, Ø., Edström, B., & Kreiner, S. (1998) · Contraception · doi:10.1016/s0010-7824(98)00033-x · Cited by 186
Lewis, M. A., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Spitzer, W. O. (1996) · Contraception · doi:10.1016/0010-7824(96)00112-6 · Cited by 183
Goodacre, S., Sampson, F., Stevenson, M., Wailoo, A., Sutton, A., Thomas, S., Locker, T., & Ryan, A. (2006) · Health Technology Assessment · doi:10.3310/hta10150 · Cited by 180
van Hylckama Vlieg, A., Helmerhorst, F. M., & Rosendaal, F. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.211482 · Cited by 175
Self-citationMartinelli, I., Taioli, E., Bucciarelli, P., Akhavan, S., & Mannucci, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.700 · Cited by 172
Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives
Seeger, J. D., Loughlin, J., Eng, P. M., Clifford, C. R., Cutone, J., & Walker, A. M. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000279448.62221.a8 · Cited by 158
Petitti, D. B. (1979) · JAMA · doi:10.1001/jama.1979.03300110022020 · Cited by 158
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., & Grobbee, D. E. (2004) · Blood · doi:10.1182/blood-2003-04-1285 · Cited by 157
Reprint of Pharmacological profile of progestins
Sitruk-Ware, R. L. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.11.011 · Cited by 151
Tans, G., Vlieg, A. V. H., Thomassen, S., Curvers, J., Bertina, R. M., Rosing, J., & Rosendaal, F. R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04443.x · Cited by 150
Self-citationRange of published estimates of venous thromboembolism incidence in young women
Heinemann, L. A. J., & Dinger, J. C. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.018 · Cited by 149
APC resistance: biological basis and acquired influences
Castoldi, E., & Rosing, J. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03711.x · Cited by 148
Bloemenkamp, K. W. M., Rosendaal, F. R., Buller, H. R., Helmerhorst, F. M., Colly, L. P., & Vandenbroucke, J. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.65 · Cited by 141
Self-citationNightingale, A. L., Lawrenson, R. A., Simpson, E., Williams, T. J., MacRae, K. D., & Farmer, R. D. T. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500402 · Cited by 141
Gronich, N., Lavi, I., & Rennert, G. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110463 · Cited by 135
Sidney, S., Petitti, D. B., Soff, G. A., Cundiff, D. L., Tolan, K., & Quesenberry, C. P. (2004) · Contraception · doi:10.1016/j.contraception.2004.02.010 · Cited by 133
20 µg versus >20 µg estrogen combined oral contraceptives for contraception
Gallo, M. F., Nanda, K., Grimes, D. A., Lopez, L. M., & Schulz, K. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003989.pub5 · Cited by 133
Farmer, R. D. T., Lawrenson, R. A., Todd, J. ‐., Williams, T. J., MacRae, K. D., Tyrer, F., & Leydon, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00198.x · Cited by 130
Oral Contraceptives and Venous Thromboembolism: A Systematic Review and Meta-Analysis
Manzoli, L., Vito, C. D., Marzuillo, C., Boccia, A., & Villari, P. (2012) · Drug Safety · doi:10.2165/11598050-000000000-00000 · Cited by 124
Methods to Account for Attrition in Longitudinal Data: Do They Work? A Simulation Study
Kristman, V. L., Manno, M., & Côté, P. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-7919-7 · Cited by 124
Oral contraceptives and nonfatal vascular disease.
Porter, J., Hunter, Jick, H., & Stergachis, A. S. (1985) · PubMed · Cited by 123
Venous thromboembolism amng new users of different oral contraceptives.
Herings, R. M. C., Urquhart, J., & Leufkens, H. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01257-x · Cited by 115
Venous thromboembolism in relation to oral contraceptive use.
Helmrich, S. P., Rosenberg, L. A., Kaufman, D. W., Strom, B. L., & Shapiro, S. (1987) · PubMed · Cited by 111
A Prospective Investigation of Pulmonary Embolism in Women and Men
Quinn, D. A. (1992) · JAMA · doi:10.1001/jama.1992.03490130077034 · Cited by 105
Oral contraceptives and fatal pulmonary embolism
Parkin, L., Skegg, D. C. G., Wilson, M., Herbison, P., & Paul, C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02382-5 · Cited by 100
Roach, R. E. J., Lijfering, W. M., Helmerhorst, F. M., Cannegieter, S. C., Rosendaal, F. R., & Vlieg, A. V. H. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12060 · Cited by 99
Self-citationDinger, J., Assmann, A., Möhner, S., & Minh, T. D. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910791749416 · Cited by 98
Barsoum, M. K., Heit, J. A., Ashrani, A. A., Leibson, C. L., Petterson, T. M., & Bailey, K. R. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.08.010 · Cited by 98
Thijs, V., Lemmens, R., & Fieuws, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn106 · Cited by 91
Tick, L. W., Doggen, C. J. M., Rosendaal, F. R., Faber, W. R., Bousema, M. T., Mackaay, A. J. C., van Balen, P., & Kramer, M. H. H. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04065.x · Cited by 91
Self-citationRisk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study
Thorogood, M., Mann, J. I., Murphy, M. S., & Vessey, M. P. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.1.48 · Cited by 90
Lindqvist, P. G., Epstein, E., & Olsson, H. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07460.x · Cited by 86
What is the best evidence for determining harms of medical treatment?
Vandenbroucke, J. P. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051484 · Cited by 83
The differential risk of oral contraceptives: the impact of full exposure history*
Lewis, M. A., MacRae, K. D., Kühl-Habich, D., Bruppacher, R., Heinemann, L. A. J., & Spitzer, W. O. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1493 · Cited by 80
Hormone therapies and venous thromboembolism: where are we now?
Vlieg, A. V. H., & Middeldorp, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04148.x · Cited by 79
Thrombotic diseases in young women and the influence of oral contraceptives
Lidegaard, Ø. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1053/ob.1998.v179.a91674 · Cited by 77
Types of combined oral contraceptives used by US women
Hall, K. S., & Trussell, J. (2012) · Contraception · doi:10.1016/j.contraception.2012.05.017 · Cited by 74
Vandenbroucke, J. P., Helmerhorst, F. M., Bloemenkamp, K. W. M., & Rosendaal, F. R. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70289-8 · Cited by 73
Self-citationVenous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use
Legnani, C., Palareti, G., Guazzaloca, G., Cosmi, B., Lunghi, B., Bernardi, F., & Coccheri, S. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3082 · Cited by 73
Oral contraceptives and nonfatal vascular disease--recent experience.
Porter, J., Hunter, Danielson, D. A., Jick, H., & Stergachis, A. S. (1982) · PubMed · Cited by 73
Progestins and Antiprogestins in Clinical Practice
Sitruk-Ware, L. R., & Mishell, D. R. (1999) · Medical Entomology and Zoology · Cited by 71
Jick, S. S., Kaye, J. A., Russmann, S., & Jick, H. (2006) · Contraception · doi:10.1016/j.contraception.2006.02.002 · Cited by 69
Kemmeren, J. M., Meijers, J. C. M., Bouma, B. N., Grobbee, D. E., & Algra, A. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612973 · Cited by 67
Todd, J. ‐., Lawrenson, R. A., Farmer, R. D. T., Williams, T. J., & Leydon, G. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1500 · Cited by 61
Andersen, B. S., Olsen, J., Nielsen, G. L., Steffensen, F. H., Sørensen, H. T., Bæch, J., & Gregersen, H. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614213 · Cited by 57
Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
(1998) · PubMed · Cited by 57
Benefits and harms of drug treatments
Vandenbroucke, J. P. (2004) · BMJ · doi:10.1136/bmj.329.7456.2 · Cited by 53
Thrombophlebitis among oral and nonoral contraceptive users.
la Haba, A. F.-D., Jo, C., Pelegrina, I., et al. (1971) · PubMed · Cited by 52
Oral contraceptives and nonfatal vascular disease: Recent experience
Conrad, L. C. A. (1983) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(83)80583-6 · Cited by 50
Dj, G., Hw, O., & Levy, M. F. (1973) · PubMed · Cited by 50
Farmer, R. D. T., Todd, J. ‐., Lewis, M. A., MacRae, K. D., & Williams, T. J. (1998) · Contraception · doi:10.1016/s0010-7824(98)00002-x · Cited by 49
Hirvonen, E., & Idänpään-Heikkilä, J. J. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90568-r · Cited by 47
Rad, M., Kluft, C., Ménard, J., Burggraaf, J., de Kam, M. L., Meijer, P., Sivin, I., & Sitruk-Ware, R. L. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.12.007 · Cited by 46
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables
Kluft, C., Meijer, P., LaGuardia, K. D., & Fisher, A. C. (2008) · Contraception · doi:10.1016/j.contraception.2007.10.004 · Cited by 46
Gomes, M. P. V., & Deitcher, S. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1965 · Cited by 44
Risk factors for venous thromboembolism in pre-and postmenopausal women
Bergendal, A., Bremme, K. A., Hedenmalm, K., Lärfars, G., Odeberg, J., Persson, I. R., Sundström, A., & Kieler, H. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.05.024 · Cited by 43
Combined oral contraceptives: risks and benefits
Thorogood, M., & VILLARD‐MACKINTOSH, L. (1993) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072592 · Cited by 41
Seaman, H. E., de Vries, C. S., & Farmer, R. D. T. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.896 · Cited by 41
Heinemann, L. A. J., Dinger, J. C., Assmann, A., & Minh, T. D. (2010) · Contraception · doi:10.1016/j.contraception.2009.12.014 · Cited by 39
Heinemann, L. A. J., Lewis, M. A., Assmann, A., et al. (2002) · Contraception · doi:10.1016/s0010-7824(01)00309-2 · Cited by 37
Pearce, H., Layton, D., Wilton, L., & Shakir, S. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02373.x · Cited by 35
Eng, P. M., Seeger, J. D., Loughlin, J. E., Clifford, C. R., Sherry Mentor, B. A., & Walker, A. M. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1554 · Cited by 34
Thrombophilias and gynaecology
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., & Vandenbroucke, J. P. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(03)00015-4 · Cited by 31
Self-citationHedenmalm, K., Samuelsson, E. C., & Spigset, O. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.0533.x · Cited by 26
Cardiovascular Diseases and the Risk of Venous Thromboembolism: A Hospital-based Case-control Study
Yang, C., & Kao, C. (2007) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70339-9 · Cited by 23
Bird, S. T., Delaney, J. A. C., Etminan, M., Brophy, J. M., & Hartzema, A. G. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12224 · Cited by 22
Trinational case–control study of oral contraceptives and health
Spitzer, W. O., Thorogood, M., & Heinemann, L. A. J. (1993) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630020105 · Cited by 22
ANOVULANTS: THROMBOSIS AND OTHER ASSOCIATED CHANGES
Grounds, M. (1974) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb70899.x · Cited by 20
Heinemann, L. A. J., Garbe, E., Farmer, R. D. T., et al. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500392 · Cited by 19
Weiss, N. S. (1997) · Contraception · doi:10.1016/s0010-7824(97)00002-4 · Cited by 19
Burnhill, M. S. (1999) · PubMed · Cited by 18
Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis
Martinelli, I., Battaglioli, T., & Mannucci, P. M. (2003) · Pharmacogenetics · doi:10.1097/00008571-200310000-00002 · Cited by 18
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Bouma, B. N., & Grobbee, D. E. (2002) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200207000-00001 · Cited by 17
Venous thromboembolism and oral contraceptives
Herings, R., Urquhart, J., & Leufkens, H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77606-6 · Cited by 17
Realini, J. P., Encarnacion, C. E., Chintapalli, K. N., et al. (1997) · PubMed · Cited by 17
Effect of Age on Oral Contraceptive-Induced Venous Thrombosis
Girolami, A., Spiezia, L., Girolami, B., Zocca, N., & Luzzatto, G. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000308 · Cited by 16
Pini, M., Scoditti, U., Caliumi, F., et al. (1996) · PubMed · Cited by 16
Oral contraceptives and thrombosis
Carter, C. J. (2000) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200007000-00008 · Cited by 15
Fatal Venous Thromboembolism Associated with Different Combined Oral Contraceptives
Hedenmalm, K., & Samuelsson, E. C. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00007 · Cited by 9
Tzankova, V., Петров, В. В., & Danchev, N. (2010) · Biotechnology & Biotechnological Equipment · doi:10.2478/v10133-010-0054-y · Cited by 7
Venous thromboembolism and oral contraceptives
Bloemenkamp, K. W. M., Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90187-3 · Cited by 7
Self-citationCardiovascular disease and use of oral contraceptives. WHO Collaborative Study.
(1989) · Europe PMC (PubMed Central) · Cited by 4
[Oral contraceptives and thrombosis].
Lidegaard, Ø., Schiødt, A. V., & Poulsen, E. F. (2001) · PubMed · Cited by 3
Meinel, H., Göretzlehner, G., & Heinemann, L. (1988) · PubMed · Cited by 3
Ulmer, H., Pfeifer, C., Pfeiffer, K. P., & Bruppacher, R. (1997) · Sozial- und Präventivmedizin · doi:10.1007/bf01318609 · Cited by 2
Research works printed but not linked: 31
- Farmer, 1996, Safety of modern oral contraceptives, Lancet, 347, 259
- Samuelsson, 2004, Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users, Acta Obstet Gynecol Scand, 83, 674, 10.1111/j.0001-6349.2004.00574.x · doi:10.1111/j.0001-6349.2004.00574.x
- Amundsen, 2000, Tidsskr, Nor Laegeforen, 120, 326
- Austin, 2009, Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women, Am J Obstet Gynecol, 200, 620. e1-620.e3, 10.1016/j.ajog.2009.01.038 · doi:10.1016/j.ajog.2009.01.038
- Barsoum, 2010, A population-based case-control study, Thrombosis Research, 126, 373-8
- Bernstein, 1986, Pulmonary Embolism in Adolescents, AJDC, 140, 667
- Bonifacj, 1997, Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine, Rev Epidemiol Sante Publique, 45, 465
- Burnhill, 1999, Int J Fertil, Womens Med, 44, 19
- Diddle, 1978, Oral contraceptives steroids and thrombophlebitis, J Tenn Med Assoc, 71, 22-26
- Fuertes, 1971, Thrombophlebitis among oral contraceptives for contraception, Obstet Gynecol, 38, 259
- Heuser, 2004, Specific oral contraceptive use and venous thromboembolism resulting in hospital admission, N Z M J, 117, U1176
- Anonymous, 1976, IPPF, Med Bull, 10, 2
- Kieler, 2003, Thromboembolism and combined oral contraceptives. Spontaneous reporting of adverse drug reactions indicate at least similar risk with themost recent contraceptives, Läkartidningen, 100, 3050
- Lambrekht, 1986, [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases], Khirurgiia (Mosk), 12, 90
- Lawrenson, 2000, Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?, Contraception, 62, 21S-28S, 10.1016/S0010-7824(00)00147-5 · doi:10.1016/s0010-7824(00)00147-5
- Lewis, 1997, The role of bias in observational studies, Contraception, 55, 189
- Lis, 1993, A concurrent cohort study of oral contraceptive use and cardiovascular risks, Pharmacoepidemiol Drug Saf, 2, 51, 10.1002/pds.2630020107 · doi:10.1002/pds.2630020107
- Ludwig, 1970, Ovulationshemmer und Venenerkrankungen, Ergebnisse der Angiologie und Phlebologie, 4, 81-102
- Meurer, 2001, What is the risk of venous thromboembolism (VT) among women taking third generation oral contraceptives ((COCs) in comparison with those taking contraceptives containing levonorgestrel?, The Journal of Family Practice, 50, 108
- Overgaard, 1986, [Venous thromboembolic disease and oral contraceptives], Ugeskr Laeger, 148, 2348
- Poulter, 1996, Safety of combined oral contraceptive pills (letter), Lancet, 347, 547
- Reed, 2012, VTE risk in users of combined oral contraceptives: Impact of a 24-day regimen containing drospirenone, Pharmacoepidemiology and Drug Safety, Conference, 169
- Seigel, 1969, Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States, American Journal of Epidemiology, 90, 11, 10.1093/oxfordjournals.aje.a121045 · doi:10.1093/oxfordjournals.aje.a121045
- Tosetto, 2003, Prevalence and risk factors of venoud non-fatal venous thromboembolism in the active population of the VITA project, J Thromb Haermost, 1, 1724, 10.1046/j.1538-7836.2003.00313.x · doi:10.1046/j.1538-7836.2003.00313.x
- Tsankova, Ginekol, 2010, 49, 8
- Vallee, [Risk of venous thromboembolism among users of third-generation oral contraceptives], Presse Med, 30, 535
- Worralurt, 2005, Risk factors of venous thromboembolism (VT) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience, J Med Assoc Thai, 88, 1502
- Henzl, 2000, Pharmacology of progestins: 17 alpha-hydroxyprogesterone derivatives and progestins of the first and second generation, 101
- Kuhl, 1998, Dienogest, Drugs, 56, 834, 10.2165/00003495-199856050-00008 · doi:10.2165/00003495-199856050-00008
- Qaseem, 2007, The Joint American Academy of Family Physicians/American College of Physicians Panel on deep venous thrombosis/pulmonary embolism. Practice guideline from the American Academy of Family Physicians and the American College of Physicians, Annals of Family Medicine, 5, 57, 10.1370/afm.667 · doi:10.1370/afm.667
- Wharton, 1988, Lower dose pills, Population Reports, 16, 1
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
Vetvik, K. G., & MacGregor, E. A. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30293-9 · Cited by 728
Pastori, D., Cormaci, V. M., Marucci, S., Franchino, G., Del Sole, F., Capozza, A., Fallarino, A., Corso, C., Valeriani, E., Menichelli, D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043169 · Cited by 324
Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Metadata
- Authors
- de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-03-03
- Volume
- 2014
- Issue
- 3
- Pages
- CD010813-CD010813
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1574745824
- Cited by
- 399
- References
- 132
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.